Who Supplies Lorazepam? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Lorazepam exports, with 24+ registered manufacturers shipping to buyers across 21+ countries — yet a handful of companies dominate the shipments. APL HEALTHCARE LIMITED holds the largest share at 37.7% (export value: $947.1K). Close behind, CENTAUR PHARMACEUTICALS PRIVATE LIMITED (17.5%, $439.8K). VENOR PHARMA LIMITED (9.0%, $227.2K). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Lorazepam? Top Manufacturers & Their Buyers
Flow of Lorazepam from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Lorazepam Supplier Network — Key Market Intelligence
The Lorazepam export market from India is led by APL HEALTHCARE LIMITED, which alone commands a 37.7% share, shipping $947.1K worth of product across 19 shipments. The second-largest exporter, CENTAUR PHARMACEUTICALS PRIVATE LIMITED, contributes $439.8K (17.5%) to the overall market. Combined, the top two suppliers alone account for 55.2% of all Lorazepam exports, indicating a relatively concentrated supply base.
Across all 24 tracked manufacturers, the total Lorazepam export value stands at $2.5M from 125 shipments. The market average shipment value is $20.1K. The single largest buyer relationship in terms of trade value is XXROBXXDO XXARMXXUSAXX INXX, receiving $454.5K worth of product.
The combined buyer network spans 11 named purchasing companies, including XXROBXXDO XXARMXXUSAXX INXX, AUROBINDO PHARMA USA INC, ORION CORPORATION, SPIRIG HEALTHCARE AG, RIVOPHARM UK LTD C/O and 6 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1APL HEALTHCARE LIMITED
APL HEALTHCARE LIMITED is the first-largest Lorazepam exporter from India, with a market share of 37.7% and a total export value of $947.1K across 19 shipments. Their average shipment value of $49.8K is above the market average of $20.1K, suggesting premium or bulk contract pricing.
APL HEALTHCARE LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• XXROBXXDO XXARMXXUSAXX INXX — $454.5K across 9 shipments (48.0% of this supplier's total exports)
• AUROBINDO PHARMA USA INC — $427.0K across 9 shipments (45.1% of this supplier's total exports)
• XXROBXXDO XXARMXXUSAXX INXX — $65.6K across 1 shipments (6.9% of this supplier's total exports)
Key Insight: APL HEALTHCARE LIMITED's per-shipment value of $49.8K is 148% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.
2CENTAUR PHARMACEUTICALS PRIVATE LIMITED
CENTAUR PHARMACEUTICALS PRIVATE LIMITED is the second-largest Lorazepam exporter from India, with a market share of 17.5% and a total export value of $439.8K across 30 shipments. Their average shipment value of $14.7K is below the market average of $20.1K, reflecting a high-volume, competitive pricing strategy.
CENTAUR PHARMACEUTICALS PRIVATE LIMITED serves 5 named buyers in our database. ORION CORPORATION is the dominant customer, accounting for 54.0% of this supplier's tracked business. Top customers include:
• ORION CORPORATION — $237.4K across 16 shipments (54.0% of this supplier's total exports)
• SPIRIG HEALTHCARE AG — $132.8K across 9 shipments (30.2% of this supplier's total exports)
• RIVOPHARM UK LTD C/O — $45.7K across 3 shipments (10.4% of this supplier's total exports)
• ORION CORPORATION — $21.8K across 1 shipments (5.0% of this supplier's total exports)
• CORPORACION FARMACEU — $2.1K across 0 shipments (0.5% of this supplier's total exports)
Key Insight: CENTAUR PHARMACEUTICALS PRIVATE LIMITED operates with high shipment frequency (30 shipments) at a per-shipment value of $14.7K, indicating a broad distribution network with many smaller, regular orders.
3VENOR PHARMA LIMITED
VENOR PHARMA LIMITED is the third-largest Lorazepam exporter from India, with a market share of 9.0% and a total export value of $227.2K across 3 shipments. Their average shipment value of $75.7K is above the market average of $20.1K, suggesting premium or bulk contract pricing.
VENOR PHARMA LIMITED serves 2 named buyers in our database. STATE PHARMACEUTICAL is the dominant customer, accounting for 99.0% of this supplier's tracked business. Top customers include:
• STATE PHARMACEUTICAL — $224.8K across 3 shipments (99.0% of this supplier's total exports)
• TO THE ORDER OF — $2.3K across 0 shipments (1.0% of this supplier's total exports)
Key Insight: VENOR PHARMA LIMITED's per-shipment value of $75.7K is 277% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.
4ESJAY PHARMA PRIVATE LIMITED
ESJAY PHARMA PRIVATE LIMITED is the fourth-largest Lorazepam exporter from India, with a market share of 8.0% and a total export value of $200.0K across 4 shipments. Their average shipment value of $50.0K is above the market average of $20.1K, suggesting premium or bulk contract pricing.
ESJAY PHARMA PRIVATE LIMITED serves 2 named buyers in our database. ANIP ACQUISTION COMPANY is the dominant customer, accounting for 66.6% of this supplier's tracked business. Top customers include:
• ANIP ACQUISTION COMPANY — $133.3K across 3 shipments (66.6% of this supplier's total exports)
• THE PURCHASE MANAGER — $66.7K across 1 shipments (33.4% of this supplier's total exports)
Key Insight: ESJAY PHARMA PRIVATE LIMITED's per-shipment value of $50.0K is 149% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.
5J B CHEMICALS PHARMACEUTICALS LIMITED
J B CHEMICALS PHARMACEUTICALS LIMITED is the fifth-largest Lorazepam exporter from India, with a market share of 5.3% and a total export value of $133.9K across 5 shipments. Their average shipment value of $26.8K is above the market average of $20.1K, suggesting premium or bulk contract pricing.
J B CHEMICALS PHARMACEUTICALS LIMITED serves 1 named buyer in our database. GENESIS PHARMACEUTICALS LIMITED. is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:
• GENESIS PHARMACEUTICALS LIMITED. — $133.9K across 5 shipments (100.0% of this supplier's total exports)
Key Insight: J B CHEMICALS PHARMACEUTICALS LIMITED's per-shipment value of $26.8K is 33% above the market average of $20.1K, consistent with large-order contracts or value-added formulations.
6J B CHEMICALS AND PHARMACEUTICALS LIMITED
J B CHEMICALS AND PHARMACEUTICALS LIMITED is the fifth-largest Lorazepam exporter from India, with a market share of 5.1% and a total export value of $127.4K across 19 shipments. Their average shipment value of $6.7K is below the market average of $20.1K, reflecting a high-volume, competitive pricing strategy.
J B CHEMICALS AND PHARMACEUTICALS LIMITED serves 3 named buyers in our database. GENESIS PHARMACEUTICALS LIMITED. is the dominant customer, accounting for 89.2% of this supplier's tracked business. Top customers include:
• GENESIS PHARMACEUTICALS LIMITED. — $113.7K across 17 shipments (89.2% of this supplier's total exports)
• GENESIS PHARMACEUTICALS LIMITED. — $13.7K across 2 shipments (10.8% of this supplier's total exports)
• SYNERGY HEALTH UTREC — $0 across 0 shipments (0.0% of this supplier's total exports)
Key Insight: J B CHEMICALS AND PHARMACEUTICALS LIMITED operates with high shipment frequency (19 shipments) at a per-shipment value of $6.7K, indicating a broad distribution network with many smaller, regular orders.
From Indian Factories to Global Pharmacies — How Lorazepam Flows
Once Lorazepam leaves the manufacturing plants of companies like APL HEALTHCARE LIMITED and CENTAUR PHARMACEUTICALS PRIVATE LIMITED, it travels to 5 destination markets with a combined import value of $2.5M. United States absorbs the largest share at 45.6% ($1.1M), followed by Sri Lanka (13.4%) and United Kingdom (13.4%).
In United States — the top destination — named importers include XXROBXXDO XXARMXXUSAXX INXX, AUROBINDO PHARMA USA INC, ANIP ACQUISTION COMPANY.
This geographic spread reflects Lorazepam's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Lorazepam Go? Top Importing Countries & Their Buyers
Trade flow of Lorazepam exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1United States
United States ranks as the first-largest destination for Lorazepam imports from India, with a total trade value of $1.1M across 22 shipments — representing a 45.6% share of all Lorazepam exports. The average shipment value of $52.1K is above the global average of $20.1K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Lorazepam importers in United States: XXROBXXDO XXARMXXUSAXX INXX is the largest buyer, accounting for 39.6% ($454.5K) of this market's total imports.
• XXROBXXDO XXARMXXUSAXX INXX — $454.5K (39.6% of United States's total)
• AUROBINDO PHARMA USA INC — $427.0K (37.2% of United States's total)
• ANIP ACQUISTION COMPANY — $133.3K (11.6% of United States's total)
Key Insight: United States's per-shipment average of $52.1K (159% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
United States is a key market for Lorazepam imports from India.
2Sri Lanka
Sri Lanka ranks as the second-largest destination for Lorazepam imports from India, with a total trade value of $337.2K across 0 shipments — representing a 13.4% share of all Lorazepam exports. The average shipment value of $337.2K is above the global average of $20.1K, indicating high-value procurement contracts or branded formulations.
Key Insight: Sri Lanka's per-shipment average of $337.2K (1576% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Sri Lanka is a key market for Lorazepam imports from India.
3United Kingdom
United Kingdom ranks as the third-largest destination for Lorazepam imports from India, with a total trade value of $336.0K across 20 shipments — representing a 13.4% share of all Lorazepam exports. The average shipment value of $16.8K is below the global average of $20.1K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Lorazepam importers in United Kingdom: GENESIS PHARMACEUTICALS LIMITED is the largest buyer, accounting for 52.5% ($176.4K) of this market's total imports.
• GENESIS PHARMACEUTICALS LIMITED — $176.4K (52.5% of United Kingdom's total)
• GENESIS PHARMACEUTICALS LIMITED. — $113.7K (33.8% of United Kingdom's total)
Key Insight: United Kingdom receives frequent, smaller shipments of Lorazepam — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
United Kingdom is a key market for Lorazepam imports from India.
4Finland
Finland ranks as the fourth-largest destination for Lorazepam imports from India, with a total trade value of $282.4K across 16 shipments — representing a 11.2% share of all Lorazepam exports. The average shipment value of $17.6K is below the global average of $20.1K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.
Named Lorazepam importers in Finland: ORION CORPORATION is the largest buyer, accounting for 92.3% ($260.6K) of this market's total imports.
• ORION CORPORATION — $260.6K (92.3% of Finland's total)
• ORION CORPORATION, — $21.8K (7.7% of Finland's total)
Key Insight: Finland receives frequent, smaller shipments of Lorazepam — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.
Finland is a key market for Lorazepam imports from India.
5Switzerland
Switzerland ranks as the fifth-largest destination for Lorazepam imports from India, with a total trade value of $132.8K across 4 shipments — representing a 5.3% share of all Lorazepam exports. The average shipment value of $33.2K is above the global average of $20.1K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Lorazepam importers in Switzerland: SPIRIG HEALTHCARE AG is the largest buyer, accounting for 100.0% ($132.8K) of this market's total imports.
• SPIRIG HEALTHCARE AG — $132.8K (100.0% of Switzerland's total)
Key Insight: Switzerland's per-shipment average of $33.2K (65% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Switzerland is a key market for Lorazepam imports from India.
People Also Ask — Lorazepam Supplier & Trade Network
Who are the top suppliers of Lorazepam from India?+
Which companies buy Lorazepam from Indian manufacturers?+
Where does Lorazepam exported from India go?+
What is the market share of the top Lorazepam supplier from India?+
What is the average shipment value for Lorazepam exports from India?+
Is Lorazepam manufactured in India and exported globally?+
Which country imports the most Lorazepam from India?+
Who are the buyers of Lorazepam in Sri Lanka?+
How concentrated is the Lorazepam supplier market in India?+
How do I find verified buyers for Lorazepam in specific countries?+
Lorazepam Trade Network — Key Takeaways
- 1APL HEALTHCARE LIMITED is India's dominant Lorazepam exporter with a 37.7% market share and $947.1K in total exports — making it the single most important sourcing entity in this market.
- 2The top 24 suppliers collectively account for 82.6% of all tracked Lorazepam exports, with a combined trade value of $2.5M.
- 3United States is the largest destination market, absorbing 45.6% of India's Lorazepam exports ($1.1M). Sri Lanka (13.4%) and United Kingdom (13.4%) follow.
- 4With 125 total shipments averaging $20.1K each, the Lorazepam export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include XXROBXXDO XXARMXXUSAXX INXX, AUROBINDO PHARMA USA INC, ORION CORPORATION, SPIRIG HEALTHCARE AG — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 3 customers
6 suppliers → 21 countries
Network value: $2.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Lorazepam — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lorazepam.
- 2.Flow Mapping: 24 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 125 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 21 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
125 Verified Shipments
24 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists